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ABSTRACT

1571

A subgenomic promoter of a positive strand RNA virus is
disclosed which directs the amplified expression of a structural gene in plant tissue. The core region and an upstream
activating domain of the subgenomic promoter are identified. This promoter can be utilized in a modified virus, or in
an appropriate engineered recombinant DNA derivative,
which may be chromosomally integrated or maintained as an
episome in transformed cells.

7 Claims, 8 Drawing Sheets
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1
SUBGENOMIC PROMOTER
This is a continuation of application Ser. No. 081197,222,
filed Feb. 16, 1994, now abandoned, which is continuation
of application Ser. No. 081069,457, filed Jun. 1, 1993, now 5
abandoned, which is a continuation of application Ser. No.
071683,516, filed Apr. 8, 1991, now abandoned, which is a
continuation of application Ser. No. 071168,691. filed Mar.
16,1988, now abandoned, and a continuation-in-partof Ser.
No. 071368,939, filed Jun. 19, 1989, now abandoned, which 10
is continuation of Ser. No. 061709,181, filed Mar. 7, 1985,
now abandoned.

FIELD OF THE INVENTION
The field of this invention is the area of molecular
biology, and it relates in particular to the field of (+) strand
RNA viruses. The teachings of the present invention will
enable the use of a viral control sequence, termed a subgenomic promoter, for directed gene expression in the appropriate cell host. Specifically, the subgenomic promoter of
RNA3 of brome mosaic virus is exemplified to amplify the
expression of a structural gene in plant tissue.
BACKGROUND OF THE INVENTION
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Single-stranded RNA viruses which are capable of replicating in the cytoplasm of host cells are widespread in
nature. Those single-stranded viruses with message-sense
genomic RNA molecules are called (+) strand, or positive 30
strand, RNA viruses. Among the known (+) strand RNA
viruses there are bacteria-specific, animal-specific, and
plant-specific varieties. There is much diversity in the morphology of virus particles, coat proteins, genetic organization, and genome size. The (+) strand RNA viruses include, 35
but are not limited to, Q-beta bacteriophage, poliovirus and
alphaviruses (including Sindbis virus) of animal cells, and
the bromoviruses (including brome mosaic virus) and the
comoviruses (including cucumber mosaic virus) of plants.
A general review of (+) strand virus replication has been 40
(1983)
T ~ ~
published (E. straUss
and J. straUss
~ ~ ~Immunol.
~ ~105:1).
b Ai ~ ~~summary
~i ~. offthe steps
follows. Virally determined proteins may be required
together with the genomic RNA(S) for infection to occur, or
all the viral proteins required to initiate virus replication may 45
be synthesized using the incoming viral genomic RNA as
message. There is no DNA intermediate in the replication of
the nucleic acid of these viruses; the replication of the
genetic infomation of a (+) strand RNA virus requires the
RNA-dependent RNA synthetic capability of cells infected 50
with such viruses. The incoming genomic (+I strand serves
as template for the synthesis of (-) strand molecules, and
then progeny (+) strands are synthesized using the (-)
strands as templates. At the latter step there is an amplification of (+) strands over (-) strand molecules. The (+) 55
strand viral RNA molecule(s) are generally translated, at
least in part, to yield virus-specificreplicase. The (-) strands
serve as the templates for subsequent synthesis of large
numbers of (+) strands which may cany structural genes and
which are destined to become encapsidated by coat protein. 60
Structural proteins are translated from genomic RNA or
from subgenomic RNA, depending on the virus. In the
instance of the (+) strand viruses with multicomponent RNA
genomes, the RNA molecules may be encapsidated in separate viral particles, in which case the host cell must be 65
simultaneously infected with each component to yield a
productive infection.

The plant (+) strand RNA viruses have been classified into
two supergroups (R. Goldbach (1986) Ann. Rev. Phytopathol. 24:289). The picomavirus-like supergroup includes
comoviruses, nepoviruses, and polyviruses, while the second supergroup includes those viruses which resemble the
animal alphavirus Sindbis virus: the tobamoviruses, tobraviruses, bromoviruses, cucurnoviruses, and alfalfa mosaic
virus. Although the (+) strand RNA viruses of plants and
animals are diverse with respect to host range, genome and
particle structures, and exact mechanisms of viral replication, there are some amino acid and nucleic acid sequence
homologies (reviewed in R. Goldbach (1987) Microbiol.
Sci. 4:197). Amino acid sequence homologies have been
described for poliovirus, foot-and-mouth disease and cowpea mosaic viruses (H. Franssen et al. (1984) EMBO
J.3:855), and for nonstructural proteins encoded by brome
mosaic virus, alfalfa mosaic virus, tobacco mosaic virus and
Sindbis virus (J. Haseloff et al. (1984) Proc. Nat. Acad. Sci.
USA 81:4358; P. Ahlquist et al. (1985) J. Virol. 53536). The
homologous regions within the nonstructural proteins are
believed to reflect mechanistic similarities in the replication
of viral nucleic acid and possibly evolutionary relationships.
The alphaviruses and the Sindbis-like plant viruses also
share a common strategy for synthesis of coat protein (and
in some cases for the synthesisof additional prokin(s). That
strategy is the use of an internal promoter to direct the
synthesis of ha (+) strand RNA moiecu~e,called a subgenomic RNA, using the (-1 strand as template. The subgenomic RNA comprises a subset of sequences found in the
corresponding "genomic" (full-length) M A 9 and may be
encapsidated in viral particles. In the case of the brome
mosaic virus (BMV), (+) strand RNA molecules outnumber
the full-length (-1 strand template about 100 to 1, and
subgenomic and full-length genomic RNAs are made in
approximately equimolar an~ounts(French and Ahlquist
(1987) J. Viral. 61:1457). The subgenomic mRNA, which in
BMV carries only the message for coat protein, is very
effectively translated by the cellular protein synthetic
machine~y.For example, gram quantities of BMV-infected
plant tissue synthesize milligram amounts of coat protein (L.
Lane
(1981) in Handbook of Plant Virus Infections and
.
Comparative Diagnosis, E. Kurstak, Ed., ElsevierNorthH011and9
pp.333-376).
The bromoviruses are a group of (+) strand plant viruses
with tripartite genomes. Included in this grouping are brome
mosaic V ~ SCowpea
,
chlorotic mosaic virus (CCMV), and
broadbean mosaic virus (BBMV). CCMV and BBMV infect
the dicots cowpeas and broadbeans respectively, and the host
range of BMV is the grasses, including the cereals (L. C.
Lane7 (1981) in The Handbook of Plant Virus Infections and
Comparative Diagnosis, Chapter 12, Elsevier, Amsterdam).
Barley is a Common experimental host for BMV, which has
been well characterized.
BMV strain M1 (Madison 1) (P. Ahlquist et al. (1984)
Proc. Nat. Acad. Sci. USA 81:7066) is the experimental
system chosen to exemplify the present invention. The BMV
genome is composed of three RNA molecules of unique,
known sequence: RNAl is 3234 bases in length, RNA2 is
2865 bases in length (P. Ahlquist et al. (1984) J. Mol. Biol.
172:369), and RNA3 is about 2114 bases in length (P.
Ahlquist et al. (1981) J. Mol. BioI. 153:23). Complete cDNA
clones have been produced (P:Ahlquist and M. Janda (1984)
Mol. Cell. Biol. 4:2876). RNAs 1 and 2 are individually
encapsidated; RNA3 is encapsidated together with RNA4,
the 876 base subgenomic coat protein message which is
presumed not to replicate in vivo (T. Lane (1974) Adv. Virus
Res. 19:151). RNA molecules purified from virus particles
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and transcripts prepared from cloned viral cDNA sequences
are infectious in the barley protoplast model system (P.
Ahlquist et al. (1984) Proc. Nat. Acad. Sci. USA 81:7066).
Therefore the full range of molecular biological techniques
is available for the analysis of BMV nucleic acid functional
sequences.
Experimental manipulations of the cloned BMV genome
have begun to define regions of functional importance (P.
Ahlquist and R. French (1988) in Domingo, Holland and
Ahlquist (eds.1 RNA Genetics Book 2: RNA Variability,
chapter 3, CRC Press, Orlando, Ha.). Both RNAs 1 and 2
and their gene products are required for viral RNA synthesis;
RNAsl and 2 encode nonstructural rotei ins l a and 2a
respectively, and these proteins determine RNA-dependent
RNA polymerase activity. RNA3 encodes nonstructural protein 3a and coat protein, but neither RNA3, pmtein 3~2,nor
coat protein is required for viral RNA replication (R. French
and P. Ahlquist (1986) Science 231:1294). RNA3 can be
modified by the insertion of a foreign gene in place of the
coat protein gene, or by certain deletions, without the loss of
replication ability (U.S. patent application Ser. No. 709,181,
filed Mar. 7, 1985; R. French et al. (1986) Science
23 1:1294). RNA3 has been well studied because its gene
products are not required for RNA replication (French et al.
1986). There are regions at the 5' and the 3' noncoding ends
of the molecule which have homologs on RNAs 1 and 2, and
it has been proposed that these sequences may function in
viral RNA polymerase recognition, initiation of encapsidation, protection of the molecules from cellular nucleases, or
a combination of these functions. Deletion studies using
cloned cDNA and in vitro transcripts have shown that
portions of the 5' and the 3' ends are required for genomic
RNA replication, and that there is a graded effect of deletions in the intercistronic region of RNA3 as well (R. French
and P. Ahlquist (1987) J. Virol. 61:1457). One feature of the
intercistronic region is an oligo(A) tract, ranging from
16-22 nucleotides in length in natural virus populations (P.
Ahlquist et al. (1981) J. Mol. Biol. 153:23). The subgenomic
promoter of BMV is located in the intercistronic region as
well. Neither the genomic nor the subgenomic promoters of
the BMV are recognized by host RNA polymerases; only
virally infected cells have RNA-dependent RNA polymerase
activity capable of responding to these signals.
W. Miller et al., 1985, Nature 313:68, established that the
production of RNA4, which serves as the message for coat
protein, occurs by initiation of RNA synthesis within the
RNA3 (-) strand molecule. (-) strand RNA3 templates
ending at the BglII site about 21 bases upstream of the
RNA4 initiation site were able to direct RNA4 production
(Miller et al. (1985); L. Marsh et al. (1987) in Positive
Strand RNA Kruses, New York, Alan R. Liss, Inc.,
pp.327-336. These studies and a study by R. French et al.
(1986) Science 231:1294, show that deletions and insertions
at or downstream of the SalI site, which is about 17 bases
downstream of the start site, do not interfere with subgenomic mRNA production. French et al, 1986, demonstrated
the expression of suitably inserted foreign genes by the
subgenomic pathway. Thus, BMV subgenomic promoter
activity was thought to be localized to a 37 base region
which in the cDNA clone lies between the BglII and the SalI
sites. Marsh et al. (1987) also presented evidence from in
vitro experiments that the 5' boundary of the BMV subgenomic promoter activity was not further upstream than the
BglII site about 21 bases upstream of the RNA4 start site.
Marsh et al. (1987) also stated, without evidence, that the
poly(A) tract somewhat further upstream of the RNA4
initiation site improved promoter activity. Both the studies

4
by Miller et al. (1985) and those by Marsh et al. (1987)
utilized in vitro expression experiments to examine the
requirements of transcription; their results did not indicate
that nucleotide sequence information as far upstream as -95
5 could contribute to the level of (+) strand m m A synthesis.
Neither Miller et al. (1985) nor Marsh et al. (1987) reported
activity of subgenomic transcription, since in their constructs, sequences 5' to the putative promoter were missing.
No published study has described the use of a subgenomic
10 promoter-containing fragment of nucleic acid which could
be transferred to a desired new location to generate a novel
subgenomic ~ R N A .
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SUMMARY OF THE INVENTION
The present invention teaches the use of the nucleotide
sequences which function as a subgenomic promoter of a (+)
strand RNA virus to direct the amplified expression of a
structural gene in plant tissue, animal tissue or protist cells
by RNA-dependent RNA polymerase. This is the first
instance wherein the nucleotide sequences identifying the
core region and an upstream activating domain of the
subgenomic promoter of a (+) strand virus have been identified. This subgenomic promoter can be utilized in a modified virus, or in an appropriately engineered recombinant
cDNA derivative which may be chromosomallv integrated
or maintained as an episoke in transformed cell: The
invention is exemplified by the subgenomic promoter of
RNA3 of brome mosaic virus (BMV), but the teachings of
the present invention allow a skilled artisan to select and use
subgenomic promoter sequences from similar (+) strand
RNA viruses for use in any desired cell type. The BMV
subgenomic promoter is composed of two parts: the core
promoter, identified by the nucleotide sequence from about
-21 to about +16, as in FIG.2, which is sufficient to direct
subgenomic transcription, and an activating domain, identified by the nucleotide sequence from about -95 to about
-22, as in FIG.2. The activating domain best acts to increase
the level of subgenomic transcription when said activating
domain is located upstream of and in the proper orientation
relative to said core promoter. Subgenomic transcription is
dependent on RNA-dependent RNA polymerase activity and
a (-) strand RNA molecule containing the subgenomic
promoter and the structural gene; for example the BMV
subgenomic promoter is recognized by RNA-dependent
RNA polymerase activities encoded by RNA viruses including, but not limited to, brome mosaic virus and cowpea
chlorotic mottle virus. Further improvements on the existing
art are that upstream duplication of the activating domain of
the subgenomic promoter can increase the level of subgenomic transcription over that directed by a single copy
subgenomic promoter and that multiple copies of the subgenomic promoter can direct the synthesis of more than one
subgenomic mRNA molecule from one (-) strand RNA
template.
A principal object of the invention is to provide a recombinant DNA molecule containing a DNA copy of the subgenomic promoter of a (+) strand RNA virus and a structural
gene, wherein the expression of said gene is a two step
process: pol11 of a host cell transcribes a (-) strand RNA
molecule canying the functional sequence of the subgenomic promoter and the complementary sequence of said
structural gene, wherein the synthesis of message-sense
RNA is under the control of said subgenomic promoter. In
one embodiment, the subgenomic promoter of RNA3 of
brome mosaic virus directs the expression of a downstream
structural gene. RNA polymerase II of the genetically modi-
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fied plant tissue synthesizes an RNA molecule which is a (-)
sense, functional copy of the subgenomic promoter and a (-)
sense copy of the structural gene. An RNA-dependent RNA
polymerase, which may be viral RNA replicase of BMV,
recognizes the subgenomic promoter and synthesizes a (+)
sense, or functional message-sense, RNA molecule which
can then be translated into protein. The RNA-dependent
RNA polymerase activity which responds to the BMV
subgenomic promoter on the (-) strand RNA molecule may
be from brome mosaic virus or cowpea chlorotic mottle
virus genetic information, or from a recombinant DNA
molecule encoding, for example, the la and 2a genes of
BMV, wherein said genes may be translated into protein
after transcription by RNA polymerase II of the host cell in
response to either constitutive promoter or under the regulatory control of a plant regulatory element.
It is a further object of the invention to provide a method
for the amplified gene expression in transformed cells composed of the steps of introducing into a desired host cell a
recombinant DNA molecule containing a subgenomic promoter from a (+) strand RNA virus and a structural gene,
wherein expression of the gene is under the regulatory
control of the subgenomic promoter and wherein the expression of that gene depends on transcription by host cellular
RNA polymerase II to yield a (-) strand RNA molecule
canying the active form of the subgenomic promoter and
subsequent subgenomic transcription of the gene to yield
active, (+) sense mRNA by RNA-dependent RNA polymerase activity, and then translation of the subgenomic
transcript to produce the polypeptide encoded by the structurd gene. The host polII transcription can be controlled by
a constitutive, inducible or derepressible polII promoter.
In the figures, and throughout the application, the
sequences which are the subgenomic promoter are presented
as the (+) strand sequences, which will be understood to be
the complement of the active subgenomic promoter
sequences.
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FIG. 1 presents a schematic map of BMV RNA3. Noncoding regions are shown as a single line, the 3a and coat
genes as open boxes, the oligo(A) as a small filled box, and
a bent arrow marks the position of the start of sequences
encoding subgenomic RNA4. In keeping with common 45
practice, the sequence of the packaged (+) strand is shown,
but it should be noted that the complementary sequence
serves as the template for subgenomic RNA synthesis.
Numbering in this figure, and in FIGS. 3, 4, 5 and 6,
subsequent figures, corresponds to that in the published 50
sequence for RNA3 (P. Ahlquist et al. (1981) J. Mol. Biol.
153:23). Restriction endonuclease sites are recognized on
the cDNA molecules carrying the RNA3 sequences.
FIG. 2 displays the nucleotide sequence of the AvaI-SalI
fragment of the RNA corresponding to the cDNA clone of 55
brome mosaic virus RNA3, which fragment comprises the
sequence of the BMV subgenomic promoter and the initiation site for subgenomic transcription in the (-) strand RNA
molecule. The restriction sites shown are for the corresponding cDNA. Within the sequences shown the AvaI, BglII, and 60
SalI sites bounding the core promoter are overlined and the
coat protein initiation codon and the oligo(A) tract are
underlined. A bent arrow marks the start of the subgenomic
transcript (RNA4), and the sequence of the 5' end of the
capped RNA4 molecule is given.
65
FIG. 3. Schematic diagram of the regions surrounding the
coat gene cDNA in plasmids pB3TP8 (wild-type), pB3SG5,

and pB3SG6. The AvaI-Sac1 fragment duplicated in
pB3SG5 is bracketed over the wild-type sequence and
shaded in its new locations in pB3SG5 and pB3SG6. Initiation sites for subgenomic RNAs 4 and 4' are shown by
bent arrows. For pB3SG5 and pB3SG6, the RNA4':RNA3
ratios were 2.4 and 3.3 respectively. For the wild-type
plasmid and pB3SG5 the RNA4 :RNA3 ratios were 1.2 and
0.4, respectively.
FIG. 4. Effects of 5' deletions on subgenomic promoter
activity. The sequence surrounding the 3' proximal RNA
initiation site in derivative pB3SG5, and map of deletions in
derivatives pB3SG21, 22, and 15. pB3SG11 is the plasmid
which represents the undeleted sequences. Values given for
the molar ratios of RNA4':RNA3are the averages of two or
more independent experiments.
FIG. 5. Effects of upstream duplications on subgenomic
promoter activity. Map of the intercistronic region of wildtype RNA3 (wt) and sequences duplicated in RNA3 derivatives pB3IC2, 5, and 6. In each of these derivatives the
indicated segment of intercistronic sequence is inserted as a
duplication immediately 5' to position 1015 in the RNA3
sequence. Values given for the molar ratios of RNA4':RNA3
are the averages of three independent experiments. For
comparison, RNA4':RNA3 ratios obtained with no duplications of upstream information are generally about 2.4 for
similar constructions.
FIG. 6. Production of multiple subgenomic transcripts
from individual RNA3 derivatives. Schematic maps of
RNA3 derivatives pB3SG5, 7, 9, 10, 13, and 14. On each
line open- headed arrows indicate the sites of insertion of
additional copies of the AvaI-Sac1 fragment spanning the
RNA4 initiation site. Above each arrow is given the molar
ratio of that subgenomic RNA to the genomic RNA3 derivative, averaged from two or more independent experiments.
Each .value is also represented as a histogram bar for visual
comparison. Arrows with filled heads represent the unaltered
RNA4 promoter in its wild-type context. The average ratio
of subgenomic RNA4 to genomic RNA3 production in
wild-type infection under these conditions is 1.2.
FIG. 7(A). Alignment of the AvaI-SalI sequence of BMV
RNA3 to emphasize the presence of imperfect direct repeats.
This analysis was computer-assisted. The BglII-SalI core
promoter sequence is shown within the indicated solid box.
The coat initiation codon, overlapping the SalI site, is also
marked.
FIG. 7(B). Sequence alignment showing the similarity
among BMV, the animal alphaviruses, cowpea chlorotic
mottle virus (CCMV), and alfalfa mosaic virus (ALMV)
genomic RNAs near the start of sequences encoding subgenomic rnRNAs for capsid proteins. There is a large gap in
each plant virus sequence introduced solely to achieve
alignment with the alphavirus consensus sequence. The bent
arrow shows the start of subgenomic RNA sequences and
the initiation codons of the BMV and CCMV coat protein
genes are underlined. These alignments were generated by
computer using published sequences; in no virus other than
BMV has the actual subgenomic promoter been empirically
determined. The alphavirus consensus was derived from the
sequences of Sindbis, Middelburg, Sernliki Forest, and Ross
River viruses (J.-H. Ou et al. (1982) Proc. Natl. Acad. Sci.
USA 79:5235). The ALMV RNA3 sequence is from R.
Barker et al. (1983) Nucleic Acids Res. 11:2881, and the
CCMV RNA3 sequence was determined by P. Ahlquist et al.
(1981) Cell 23:183.
FIG. 8 presents schematic representations of normal RNA
virus replication an the two-stage expression system which

relative to the start site of the subgenomic mRNA, which is
utilizes the subgenomic promoter for amplified transcripdesignated +I. The BMV subgenomic promoter comprises
tion.
the nucleotide sequence extending from about -95 to about
FIG. 8A gives the schematic of successive (-) and (+)
+17, as in FIG. 2; the sequence comprised within the region
strand synthesis amplifying viral RNAin normal infection of
from
about -74 to about +16 also constitutes a functional
host cells.
5
subgenomic promoter.
FIG. 8B gives the schematic for the similar amplification
The core promoter of a subgenomic promoter includes the
of a chrom&omal transcript by cytoplasmic synthesis of
minimum sequence required for function. In the case of
multiple complementary copies from a viral subgenomic
BMV the core promoter comprises the nucleotide sequence
promoter. The nontranslatable primary transcript, which
from about -21 to about +17, as in FIG.2. When correctly
itself is a (-) strand with respect to the coding sequence of lo positioned as is understood in the art, the core promoter is
the plant-expressible gene, is synthesized by cellular RNA
sufficient to direct the initiation of message synthesis by an
polymerase II in response to a polII promoter. RNA-depenRNA-dependent RNA polymerase so that (+)strand RNA
dent RNA polymerase activity, such as that induced by the
molecules are synthesized.
l a and 2a genes of BMV, is necessary to achieve subgeThe activating domain of a subgenomic promoter includes
nomic transcription of a (+) sense mRNA directed by the l5
sequences which increase the activity of the core promoter
subgenomic promoter sequences present in active form on
allowing for increased synthesis of subgenomic transcripts.
the (-) strand primary transcript RNA molecule. The plant
In the case of BMV, the activating domain which can
tissue can be genetically modified to contain the gene(s)
increase synthesis of mRNA directed by a subgenomic
encoding RNA-dependent RNA polymerase activity under
the regulatory control of RNA polymerase II, or that activity 20 promoter, or a subgenomic core promoter, relative to the
levels obtained when only the core promoter sequences are
can be expressed during viral infection. Because the polarity
present, comprises the nucleotide sequence between about
of the primary transcript is opposite to its product subge-95 and about -22, as in FIG. 2. Somewhat less activation
nomic RNA, translation of appropriately oriented genes only
is obtained with the sequence from about -74 to about -22.
occurs from the secondary subgenomic transcript. Thus, this
RNA dependent RNA polymerase herein refers to an RNA
scheme provides control of induction as well as amplifying 25
synthetic enzyme which faithfully initiates (+) strand RNA
expression.
synthesis in response to an RNA sequence which is a
subgenomic promoter, and which is contained within a RNA
DETAILED DESCIUPTION OF THE
molecule which is (-) sense relative to the coding region of
INVENTION
30 the associated structural gene. For example, the l a and 2a
genes of BMV determine RNA-dependent RNA polymerase
The following definitions are provided, in order to remove
activity in cells within which those genes are expressed, and
ambiguities to the intent of scope of their usage in the
that
RNA-dependent RNA polymerase activity recognizes
specification and claims.
subgenomic promoters including, but not limited to, those of
An RNA virus, as used herein, means a virus whose 35 brome mosaic virus and cowpea chlorotic mottle virus.
genome is RNA in single-stranded form, the single strand
The term subgenomic transcription refers herein to the
being a (+), or messenger-sense strand. Replication of the
synthesis
of RNA by an RNA-dependent RNA polymerase
viral (+) strand in a cell occurs by a process of direct RNA
wherein said RNA-dependent RNA polymerase uses a (-)
replication and is therefore distinguishable from the mechanism of retroviral replication which is characterized by an 40 strand of RNA as template, and wherein said RNA-dependent RNA polymerase initiates the synthesis of mRNA in
intermediate step of reverse transcription in the host cell.
response to the nucleotide sequence information contained
The term subgenomic promoter refers to those sequences
within the subgenomic promoter.
within an RNA molecule and at the 5' end of a structural
The term (+) strand RNA refers to RNA which is mesgene, which direct messenger RNA synthesis using said
senger-sense
with respect to coding regions.
RNA molecule as the template. A subgenomic promoter is 45
The term (-) sense RNA refers to sequences which are the
necessary to drive expression of genes using RNA as temcomplement of (+) sense molecules. For example, the (-)
plate; the subgenomic promoter is recognized by an RNAsense RNA molecule corresponding to a structural gene is
dependent RNA polymerase, which may be a viral RNA
complementary in sequence to the message, and the (-)
replicase. The promoter itself may be a composite of segments derived from more than one source, naturally occur- 50 sense RNA molecule cannot itself act as a message for the
translation of the corresponding protein.
ring or synthetic. It should be noted that a subgenomic
promoter is located in relation to the particular gene whose
The term polII promoter herein refers to DNA sequences
transcription it initiates, and it is functionally recognized by
at the 5' end of genes which direct the initiation of tranan RNA-dependent RNA polymerase (or viral RNA repliscription by the DNA-dependent enzyme RNA polymerase
case) when it is contained within an RNA molecule of the 55 I1 of plant or animal cells. Promoter sequences are necessary,
but not always sufficient, to drive the expression of downproper (-) polarity. The (-) sense RNA molecule containing
stream genes. The promoter itself may be a composite of
the functional copy of the subgenomic promoter, which
segments derived from more than one source, naturally
comprises the functional units of core promoter and activating domain, can be synthesized by RNA-dependent RNA
occumng or synthetic. Eukaryotic poll1 promoters are compolynerase using a (+) sense RNA molecule as template, or 60 monly identified by the presence of DNA sequences
it may have been synthesized by (cellular) RNA polymerase
homologous to the canonical form 5'-TATAA-3'
I1 as a transcript initiated by a polII promoter. A specific
("TATA" box) about 10-30 bp 5' to the location of the 5'-end
embodiment of the present invention is the subgenomic
of the mRNA (cap site, +I). About 30 bp 5' to the TATA box
promoter of RNA3 of brome mosaic virus (BMV). The
another promoter component sequence is often, but not
identifying sequence of the subgenomic promoter of BMV 65 always, found which is identified by the presence of DNA
sequences homologous to the canonical form 5'-CCAAT -3'.
is given in FIG. 2. For consistency herein, the position of the
For the purposes of the present description, a pol11 promoter
brome mosaic virus subgenomic promoter has been given
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is defined to include DNA sequence extending up to about
100 bp 5'(-100) to the cap site. Any additional sequences
which may be located 5' to -100, and which may contain
functionality including, but not limited to, that of Wanscription activating element or sequences exerting regulation in
response to environmental stimuli, are considered promoterassociated elements, but for the purposes of this application,
are considered part of the polII promoter, even though said
sequences may be recognized by cellular proteins other than
DNA-dependent RNA polymerae u. (A polymerae is
to recognize^ a particular DNA sequence if hatsequence
is necessary to or has regulatory effect on initiation of
transcription by the polymerase.) It should be noted that a
pol11 promoter is generally located 5' to the particular gene
whose transcription it initiates. That transcript may be a (+) 15
sense RNA molecule which can serve as a message or it may
be a (-) strand RNA molecule which can serve as a template
for subsequent RNA synthesis.
Expression refers to the transcription and translation of a
is made. Gene expression 20
structural gene so that a
can be assessed by direct detection of the protein
by
protein gel electrophoresis or immunological methods, for
example. Oftentimes, expression is assessed by detection of
the ~ R N Aproducts of transcription. This method is partitularly appropriate for the assessment of transcriptional 25
control factors, such as promoter elements, since the effects
of nontranscriptional processes, such as protein degradation,
are excluded.
A structural gene refers to the combination of nucleotide
sequences encoding a protein and (some of) the regulatory 30
sequences which allow expression of that structural gene in
a plant cell or tissue. The term structural gene refers to that
portion of a gene composed of a DNA segment coding for
a protein, polypeptide or portion thereof, possibly including
a ribosome binding site and/or translational start codon. The 35
term can also refer to copies of a structural gene naturally
found within the cell, but artificiallyintroduced. In this case
a structural gene naturally found in a cell may be reintroduced into a cell as part of a chimeric gene having nonnatural regulatory control sequences, for example under the 40
control of the BMV subgenomic promoter. The structural
gene may encode a protein not normally found in the plant
cell in which the gene is introduced, in which case it is
termed a foreign structural gene. A foreign structural gene
may be derived in whole or part from a bacterial genome or 45
episome, eukaryotic nuclear or plastid DNA, cDNA, viral
DNA, or chemically synthesized DNA. It is further conternplated that a structural gene may contain one or more
modifications in either the coding segments or in the
untranslated regions which could affect the biological activ- 50
ity or the chemical structure of the expression product, the
rate of expression, or the manner of expression control. Such
modifications include, but are not limited to, insertions,
deletions and substitutions of one or more nucleotides. The
structural gene may constitute an uninterrupted coding 55
sequence or it may include one or more introns, bounded by
host cell-functional splice junctions. The structural gene
may be a composite of segments derived from a plurality of
sources, naturally occurring or synthetic. That structural
gene may also produce a fusion protein. It is contemplated 60
that the introduction into host cells of recombinant DNA
containing the structural gene in combination with a subgenomic promoter or with a polII promoter will include
constructions in which the structural gene is not derived
from the same kind of cell as the host, and constructions 65
wherein additional copies of naturally occurring genes are
expressed under BMV subgenomic promoter control.
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A recombinant DNA molecule is one which has been
either naturally or artificially produced from parts derived
from heterologous sources, which parts may be naturally
occurring or chemically synthesizedmolecules, and wherein
those parts have kenjoined by ligation or other means
lcnown to the art.
Plant tissue includes differentiated and undifferentiated
tissues of plants including, but not limited to, roots, shoots,
leaves, pollen, seeds, tWTIor lissue such as crown g&sUs, and
various forms of aggregations of plant cells in culture such
as embryos and calli. The plam tissue may be in planh, or
in Organ,
Or
The term chemically synthesized, as related to a sequence
of DNA, means that the component nucleotides were
assembled in vitro using nonenz~matic n~eans.Manual
synthesis of DNA may be accomplished using well established procedures (i.e. M. Caruthers (1983) in Methodology
DNA and RNA Sequencing* Weissman (ed.)3
hblishers (New York) Chapter 1) or automated synthesis
Can be ~edormedusing one of a number of commercially
machines.
Homology as used herein, refers to identity of nucleotide
sequences. The extent of homology between DNA
Sequences can be empirically determined in DNA hybridization experiments, such as those described in B. H a m s
and S. Higgins (1985) Nucleic Acid Hybridisation, IRL
Press, Oxford, UK.
Because there is some flexibility with respect to the
it was possible to examSequences carried on BMV
ine how certain RNA sequences in the intercistronic region
contributed to subgenomic promoter activity. It was known
that initiation of subgenomic RNA synthesis does not
require more than 16 bases downstream of the start site (i.e.
3' to the Start of RNA4 sequences in the virion-sense RNA)
(W- Miller et
(1985) Nature 313:68; R. French et al.
(1986) Science 231:1294; L. Marsh et d. (1987) in Positive
Strand RNA Kruses, Alan R. Liss, Inc., New York,
pp.327-336). Infectious in vitro transcripts synthesized from
engineered RNA3 cDNA clones were used to determine the
effects of alterations in the primary structure of RNA3. A
restriction map of the cDNA clone of BMV RNA3 and the
nucleotide sequence of the Avd-SalI region surrounding the
subgenomic transcript start sites are given in FIGS. 1and 2.
A notable feature of the sequence upstream from the subgenomic message start site is an oligo(A) tract which is
conserved at equivalent genomic positions h other members
of the br~movirusgroup (P. Ahlquist et al. (1981) Cell
231183; unpublished observations). TO determine whether
the oligo(A) tract affects subgenomic Promoter activity,
mutant plasmid P B ~ I C which
~ , lacks all but one A residue,
was constructed. That in vie0 RNA3 transcript possessed
less than 10% of the parental subgenomic Promoter activity
in viva. The length of the oligo(A) tract ranges in length
from 16-22 in natural RNA3 populations (P. Ahlquist et al.
(1981) J. Mol. Biol. 153:23). In P B ~ T Pthere
~ are 18 A
residues (M. Jan& et al. (1987) Virology 158:259). Subgenomic Promoters containing oligo(A) tracts differing in
length from the 18 as in FIG. 2, will be considered functionally equivalent to the BMV subgenomic Promoter of
FIG. 2, provided that similar amounts of SeqUenCe information flanking the oligo(A) are maintained.
In the test system, parental RNA3 transcripts produced
progeny (+) strand RNAs at a ratio of RNA4:RNA3 of 1.2.
To separate the effects of sequence changes in the intercistronic region on subgenomic message production from
effects OE genomic RNA3 amplification, a second subge-
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nomic initiation site was established by inserting the AvaISacI fragment of cDNA spanning the start site at the XbaI
site of the RNA3 cDNA to create pB3SG5 (FIG. 3). pB3SG5
transcripts were replicated, and directed the synthesis of two
subgenomic RNAs as intended. The subgenomic mRNA 5
produced from the engineered copy of the subgenomic
promoter (RNA4') was more abundant than both the
genomic RNA3 and the subgenomic mRNA originating
from the wild-type subgenomic promoter. A ratio of
RNM':RNA3 of 2.41 was obtained from pB3SG5. lo
P B ~ S Gwhich
~ , contained only one COPY of the subgenomic
Promoter at the same distal location as that of P B ~ S G ~ ,
produced subgenomic and genomic W A S at a ratio of 2.5: 1.
The sizes of subgenomic RNA species obtained with
pB3SG5 and pB3SG6 were consistent with initiation from 15
the expected sites in the duplicated promoter sequences.
Primer extension experiments confirmed that the initiation
site for subgenomic WA synthesis was unchanged even
when the subgenomic promoter was moved to a new location or was duplicated within the RNA3 cDNA clone. Like 20
wild-type RNA4 @. Dasgupta et al. (1976) J. Virol. 18:260),
the subgenomic RNA produced from the novel subgenomic
RNA initiation site was capped.
Further functionality of RNA sequences in the region
upstream of the subgenomic RNA start site was examined by 25
determining the effects of a series of internal insertion and
deletion mutations on subgenomic mRNA synthesis in plant
tissue. A second functional subgenomic promoter was established distal to the intercistronic region; therefore, it was
possible to use deletion analysis to investigate the 5' limits
of sequences contributing to subgenomic RNA synthesis
without significant affects on full-length RNA3 accumulation. In protoplast infections these deletions induced an
obvious progressive decline in subgenomic W A production
as the deletions extended further 5'. The decreased accumulation must reflect reduced synthesis because the sequence
of the subgenomic WA, and therefore its stability, was
unchanged in the various constructions. The results are
summarized in FIG. 4. pB3SG11 carried the Av&SalI
fragment containing about 95 bases upstream of through
about 16 bases downstream of the start of subgenomic
transcription. The RNA4':RNA3 ratio of 2.5 was similar to
that of pB3SG5, which carried the sequence information
through the SacI site well into the coat protein gene.
pB3SG21, containing subgenomic promoter sequences from
the BstXI site about -74 through the SalI site downstream of
the start site, produced an RNAC:RNA3 ratio similar to the
RNA4:RNA3 ratio of the wild-type plasmid, but lower than
that of pB3SGll. Further deletions of the upstream region
gave further decreases in the RNA4':RNA3 ratios. pB3SG15
was the plasmid with the shortest subgenomic promoter
fragment (BglII-SalI); the RNAC:RNA3 ratio was 0.3:1,
showing that the efficiency of the truncated subgenomic
promoter was limited. Thus, the 5' end of the core promoter
is no further 5' than -21, and all information necessary for
efficient initiation is 3' to about -95, with results similar to
that of the wild-type plasmid ratio when only about 74 bases
of upstream information are present. Therefore, the BglIISalI fragment, from about -21 to about +16 as in FIG. 2,
comprises the BMV subgenomic core promoter. The A d SalI fragment, from about -95 to about +16, as in FIG. 2,
and the BstXI-SalI fragment, from about -74 to about +16,
as in FIG. 2, both contain activating domain and core
promoter activities of the subgenomic promoter.
Duplication of subgenomic promoter activating domain
sequences from the RNA3 intercistronic region at a site
some 220 bases upstream of the start site for subgenomic

30

35

40

45

50

55

60

65

transcription led to a stimulation in subgenomic RNA synthesis. The structures and the RNA4:RNA3 ratios for wildtype and the mutant plasmids is given in FIG. 5. Significant
stimulation of subgenomic RNA synthesis was achieved by
duplicating the sequence contained within the activating
domain, an AvaI-BglII fragment from about -95 to about
-21 of the cDNA of RNA3 upstream of RNA start site.
While the oligo(A) tract contributed to that stimulation, it
was not required for stimulation to occur.
To determine whether sites other than the XbaI site could
support subgenomic RNA synthesis when the AvaI-Sac1
fragment was present, the AvaI-Sac1fragment of RNA3 was
duplicated at a ClaI site 5' to the normal RNA4 start site in
pB3SG7. Both subgenomic promoters were functional, and
as in other cases where there were two copies of the
subgenomic Promoter, the smaller of the subgenomic RNAs
was more abundant. Mutant RNA3 cDNA clones were also
constructed to test whether more than two subgenomic
promoters Were functional in a single RNA3 derivative.
P B ~ S Gand
~ pB3SG10 each contained two ~vaI-SacIsubgenomic promoter fragments while pB3SG13 and pB3SG14
each contained three. It was found that the subgenomic
promoter was active at each location tested, and a distinct
gradient favoring greater accumulation of subgenomic
W A S from 3'proximal sites was observed in these experiobserved activation of subgenomic
ments (FIG. 6).
transcription is a consequence of upstream duplications of
subgenomic promoter
The ability of the subgenomic promoter fragment to
function in the reverse orientation relative to the surrounding
cDNA was tested in P B ~ S G ~and
R P B ~ S G ~ No
R . putative
subgenomic RNA species were observed. In both cases the
inversion caused severe inhibition of RNA3 accumulation.
For SG6R, with its 26 b inverted repeat, only a small amount
of RNA3 could be detected on overexPosures of the autoradiographs, but SG5R with its 330 bp inverted repeat never
gave detectable RNA3 production. NO internally initiated
''~seudo-subgenomic" RNA species of negative polarity
Were detected from either C O ~ S ~ I U C ~ ~ O ~ .
Computer-assisted sequence inspection revealed that the
120 base AvaI-SalI region of the RNA3 cDNA, which
contains the core promoter and the activating domain of the
subgenomic promoter, includes several imperfect direct
repeats (FIG. 7). The 30 bases overlapping and immediately
5' to the oligo(A) tract have 67% identity with the BglII-SalI
core promoter region, with the 3' boundary of this duplication corresponding precisely to the start of the coat protein
coding region. Immediately 5' to this duplication is a clearly
related segment which also includes a single-mismatch
repeat of the consensus element 5'-AUCUAUGUU-3'.
Thus, nearly all of the AvaI-SalI promoter region consists of
repeats or partial repeats of sequences related to the core
promoter, punctuated in one area by the oligo(A). Although
similar in sequence, the two copies of the core promoter
motif flanking the oligo(A) were clearly not equivalent.
While the 3' copy contains a weak but functional promoter,
no subgenomic RNA initiation was detected at the corresponding site in the 5' copy of this motif.
As shown in FIG. 7, the oligo(A)/core promoter region of
BMV RNA3 contains similarities to the analogous regions
near the subgenomic mRNA start sites in some other plant
WA viruses, including cowpea cNorotic mottle virus
(CCMV) and alfalfa mosaic virus (AMV). BMV is the only
(+) strand RNA virus for which the subgenomic promoter
sequences have been determined experimentally. FIG. 7 also
displays the significant homology of the sequence from the
BMV subgenomic promoter region to the consensus
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sequence from just upstream of the start of alphavirus
subgenomic RNA (taken from J.-H. Ou et al. (1982) Proc.
Natl. Acad. Sci. USA 795235-5239); the functionality of
the alphavirus consensus sequence in directing subgenomic
RNA synthesis has not been test*. The sequence simi1a1-i- 5
ties shown in FIG. 7 overlap the BMV consensus element
AUCUAUGUU which, with single mismatches, is repeated
three times in the BMV AvaI-SalI fragment (FIG. 7A).
Deletions of the upstream repeated sequences (FIG. 4)
resulted in decreased subgenomic promoter activity. Fur- lo
thermore, RNA4 synthesis was shown to proceed correctly
from a CCMV RNA3 when BMV RNAsl and 2 were
provided in a co-infection and similarly, co-infections of
BMV RNA3 with CCMV
1 and 2 yield accurately
synthesized RNA4. Previously published studies of BMV 15
subgenomic transcription were based on in vitro experimerits carried out uskg extracts made from BMV-infected
barley cells (L. Marsh et al. (1987) in Positive Strand RNA
E w e s , Alan R.Liss, Inc., New York; W. Miller et al. (1985)
Nature 313:68). The work of the present invention was zo
performed using in viva experiments to study subgenomic
RNA synthesis. The current results demonstrate that the
BglII-SalI region of cDNA for BMV RNA3 has some
subgenomic promoter activity in vivo, however, sequence
information upstream of the BglII site (the AvaI-BglII region 25
from about -95 to about -21 relative to the start site)
constitutes an activating domain which is required for efficient synthesis of subgenomic RNA by RNA-dependent
RNA polymerase. In addition, the work of the present
invention demonstrated that a fragment of DNA (e.g., the 30
AvaI-SalI fragment) containing the subgenomic promoter
could be moved to a novel location within an RNA sequence
with subgenomic promoter activity retained. Furthermore,
several subgenomic promoters have now been shown to be
functional within a single RNA3 derivative even if located 35
at separate sites leading to a plurality of subgenomic RNA
transcripts. Still further, it was determined that a fragment
carrying the activating domain of a subgenomic promoter
could be duplicated upstream of the subgenomic promoter
with the unexpected result that subgenomic transcription 40
was enhanced.
A principal feature of the present invention is the brome
mosaic virus subgenomic promoter, which is identified by
the nucleotide sequence as in HG. 2, nucleotides -95 to +16
relative to the start site for subgenomic transcription. This 45
nucleotide sequence was sufficient to direct subgenomic
RNA synthesis from a novel site on the viral genome at
wild-type or greater levels. Sequences no more than about
20 bases upstream of the start site sufficed to direct specific
initiation at a low level; therefore the region between -21 50
and +16 is termed the subgenomic core promoter. Sequences
at least as far as 74, but no more than 95 bases upstream are
required for full promoter activity. The oligo(A) tract
the region between -21 and -74 is an important functional
element in full subgenomic promoter activity, and may 55
function as a recognition sequence element or may provide
spacing or flexibility between other elements of the prometer. The function of the sequence elements with homology to the consensus element AUCUAUGUU is not known,
but analogy to DNA-dependent transcription suggests that 60
these sequences might be recognized by trans-acting fattor(s) to increase the level of subgenomic transcription.
Further increases in the level of subgenomic transcription
were obtained by duplicating the sequence information of
the AvaI-BglII fragment upstream from the start site, as in 65
FIGS. 2 and 5. The subgenomic promoter can be used to
direct the expression of a structural gene when the subge-
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nomic promoter is in a site other than its normal site within
the RNA3 derivative, and enhancement of subgenomic
transcription may be achieved by duplication of the activating domain portion of the subgenomic promoter.
From the data presented herein, location, isolation and use
of subgenomic promoters from other sources can be readily
carried out by those of ordinary skill in the art without undue
experimentation. The comparative sequence data of FIG. 7
show remarkable homology over a wide range of RNA
sources known to possess subgenomic promoters. From
such data, together with known or readily obtainable data on
subgenomic transcription start sites, subgenomic promoters
equivalent to that of BMV RNA3 can be isolated and used
as described and exemplified herein. The recognized homology and mode of action of RNA-de~endentRNA ~ 0 1 ~ merases allows for the mixed combination of subgenomic
promoter and RNA-dependent RNA polymerase from heterologous sources, or demonstrated herein for BMV and
CCMV. However, it will be understood that differences in
rate of transcription and Promoter specificity can lead to
quantitative differences in expression, depending on the
particular combination of Promoter and polymerase
employed.
It is an object of this invention to provide a method for the
amplified expression in plant tissue of a structural gene
under the regulatory control of an RNA virus subgenomic
promoter, which in one embodiment can be the subgenomic
promoter of brome mosaic virus. The method is composed
of the following steps: introducing into plant tissue a recombinant DNA molecule containing the subgenomic promoter
and a structural gene such that the expression of said gene
is under the regulatory control of the subgenomic promoter
and the entire combination is of a conventional polII promoter, either constitutive, inducible or derepressible, synthesis by cellular RNA polymerase I1 of a primary, (-) strand
transcript containing the subgenomic promoter in its active
form and the complement of the coding sequence of the
structural gene, and expression of RNA-dependent RNA
polymerase activity (for example, by the infection of the
modified plant tissue with brome mosaic virus, or by inducing chromosomally integrated copies of the BMV la and 2a
genes under the control of pol11 promoters), followed by
subgenomic transcription to yield a secondary, (+) sense
mRNA encoding the structural gene which is then translated
to yield its protein product. This scheme has the advantage
that in the absence of RNA-dependent RNA polymerase
activity the structural gene is completely silent because there
is "0 (+) sense RNAs~nthesized,and therefore, there can be
"0 translation to yield the protein product of that gene.
Generally genes under the regulatory control of regulated
poln Promoters and associated sequence elements exhibit
some degree of expression even in the absence of inducing
conditions. Use of a subgenomic promoter is therefore
~Sefulto prevent expression of a gene which would be lethal
for the cell which expresses it. When such a gene is tightly
controlled SO that it is only expressed after infection with
virus, its expression kills the infected cell before virus
replication and dissemination occur. This process constitutes
an effective I'rIeanS for contr~llingvirus infection in plant
tissue, and therefore a way to Prevent crop damage and
economic loss. The advantages of this scheme would be lost
if the control of lethal gene expression were not virtually
absolute, and are therefore not feasible with prior art pol11
Promoters.
Another consequence of the use of a subgenomic promoter is the rapid amplification of expression once an active
RNA-dependent RNA polymerase is present. The promoter

788

16
is therefore useful to express any gene when a sudden burst
of expression is desired. For example, rapid but transitory
expression of high-level herbicide resistance can be obtained
by providing a herbicide-resistance gene under subgenomic
promoter control and an RNA-dependent RNA polymerase
under control of an inducible or derepressible pol11 promoter. The latter can be chosen to turn on polymerase
expression in response to a component in the herbicide
formulation. Other specific resistances can be regulated in a
similar manner and will be especially useful where the
resistance is the result of expressing a gene that leads to
production of a toxic distasteful or otherwise undesirable
substance. High level, transitory expression of such a gene
can be achieved using an innocuous inducing agent, so as to
produce the desired resistance at precisely the desired stage
in the host organism's life cycle. Later, for example at
harvest, when the gene is not expressed, the undesirable
substance is absent from plant tissue intended for consumption.
It will be understood by those of ordinary skill in the art
that the use of subgenomic promoter-structural gene combinations is not confined to plants. Positive strand RNA
viruses exist for bacteria and animal cells as well as plants,
and subgenomic promoter homology is seen for both plant
and animal viruses. Therefore, expression of a structural
gene under subgenomic promoter control can be accomplished in any transformable cell including, without limitation, plant cells, animal cells and bacterial cells.
The production of genetically modified plant tissue containing and expressing a structural gene under the transcriptional control of the BMV subgenomic promoter combines
the specific teachings of the present disclosure with a variety
of techniques and expedients known in the art. In most
instances, alternative expedients exist for each stage of the
process. The choice of expedients depends on variables such
as the choice of vector system for the introduction and stable
maintenance of the expression complex, the cell type,
whether plant, animal or protist, to be modified and, in the
case of plants, the desired regeneration strategy, and the
particular structural gene to be used, all of which present
alternative process steps which those of ordinary skill in the
art are able to select and use to achieve a desired result.
Homologs of structural genes or of other sequences may
be identified by the ability of their nucleic acids to crosshybridize under conditions of appropriate stringency as is
well understood in the art. It will be understood that there
may be minor sequence variations within sequences utilized
or disclosed in the present application. It is well known in
the art that some DNA sequences within a larger stretch of
sequence are more important than others i n determining
functionality. A skilled artisan can test allowable variations
in sequence, without undue experimentation, by well known
mutagenic techniques which include, but are not limited to,
those discussed by D. Shortle et al. (1981) Ann. Rev. Genet.
15:265; M. Smith (1985) ibid. 19:423; D. Botstein and D.
Shortle (1985) Science 229: 1193; by linker scanning
mutagenesis (S. McKnight and R. Kingsbury (1982) Science
217:316) or by saturation mutagenesis (R. Myers et al.
(1986) Science 232:613). These variations may be determined by standard techniques in combination with assay
methods described herein to enable those skilled in the art to
manipulate and bring into utility the functional units of pol11
promoters, structural genes, and subgenomic promoters.
Using the methods described herein the skilled artisan can,
without undue experimentation, test altered sequences
within a subgenomic promoter for retention of function. The
final steps of the preferred embodiment for obtaining geneti-

cally modified plant tissue include inserting the expression
complex into a T-DNA-containing vector, and transfemng
the recombinant DNA to plant tissue wherein the modified
T-DNA becomes stably integrated as a part of the genome.
Other techniques for transforming plant cells, including
protoplast transformation, electroporation, micro-injection
and agroinfection can be employed.
The following examples are provided for illustrative
purposes only and are not intended to limit the scope of the
invention. The examples utilize many techniques well
known and accessible to those skilled in the arts of molecular biology, in the manipulation of recombinant DNA in
plant tissue, and in the culture and regeneration of transformed plants. Techniques for similar manipulations of
recombinant DNA in animal and bacterial cells are well
known. Enzymes are obtained from commercial sources and
are used according to the vendors' recommendations or
other variations known in the art. Reagents, buffers, and
cultural conditions are also known to the art. References
containing standard molecular biological procedures include
T. Maniatis et al. (1982) Molecular Cloning, Cold Spring
Harbor Laboratory, Cold Spring Harbor, N.Y.; R. Wu (ed.)
(1979) Meth. Enzymol. 68; R. Wu et al. (eds.) (1983)
Methods Enzymol. 100 and 101; L. Grossman and K.
Moldave (eds.) Methods Enzymol. (1980) 65; J. Miller (ed.)
(1972) Experiments in Molecular Genetics, Cold Spring
Harbor Laboratory, Cold Spring Harbor, N.Y.; Old and
Primrose (1981) Principles of Gene Manipulation, University of California Press, Berkeley, Calif.; R. Schlief and P.
Wensink (1982) Practical Methods in Molecular Biology,
Springer-Verlaz Berlin Glover (ed.) (1985) DNA Cloning,
Vols. I and 11, IRL Press, Oxford, UK, B. Hames and S.
Higgins (eds.) (1985) Nucleic Acid Hybridization, IRL
Press, Oxford, UK; P. Setlow and A. Hollaender (1979)
Genetic Engineering: Principles and Metho&, Vols. 1-4,
Plenum Press, New York. Abbreviations and nomenclature,
where employed, are deemed standard in the field and
commonly used in professional journals such as those cited
herein.
EXAMPLE 1
This example describes the recombinant DNA molecules
and the cloning strategies used to characterize the BMV
subgenomic promoter sequences.
1.1 Wild-Type cDNA Clones of Brome Mosaic Virus in
Transcription Vector Plasmids
Plasmids pBlTP3, pB2TP5, and pB3TP8 contain cDNA
copies of BMV RNAs 1, 2, and 3, respectively, from which
properly initiated, capped and infectious transcripts of the
complete BMV genome can be produced with T7 RNA
polymerase (M. Janda et al. (1987) Virol. 158:259). Other
plasmids used in the construction of RNA3 derivatives were
pB3TP7 (M. Janda et al. (1987) and pB3PM1 (P. Ahlquist
and M. Janda (1984) Mol. Cell. Biol. 4:2876-2882). Those
plasmids contain the same BMV cDNA region as pB3TP8,
but are linked to a T7 promoter with a single intervening G
residue, and linked directly to an E. coli promoter, respectively. All the above plasmids except pB3M1 are pUC119
derivatives, and so contain the ssDNA replication origin of
bacteriophage M13, allowing recovery of ssDNA forms
after superinfection with suitable helper phage, such as
M13K07 (provided by J. Vieira).
1.2 Plasmid Constructions with Mutant BMV Constructions
Standard methods were used with minor modifications (T.

5,466,788
17

18

Maniatis et al. (1982) Molecular Cloning, Cold Spring
Harbor Laboratory, Cold Spring Harbor, N.Y.). To join
noncomplementary ends of fragments produced by different
restriction endonucleases, 3' protruding ends were trimmed
to bluntness with T4 DNA polymerase, and 3' recessed ends 5
were extended to bluntness with either the large fragment of
E. coli DNA polymerase I or T4 DNA polymerase.
P B ~ I C E.
~ : coli RZ1032 (dut, ung) (T. Kunkel (1985)
Nat.
Sci. USA 82:488) was transformed with 10
pB3TP8 and dUTP-containing
was
after
superinfection with M13K07. This DNA was used as a
template for oligonucleotide-directed mutagenesis (Kunkel,
1985) to delete 17 of the 18 residues of the pB3TP8
intercistronic oligo(A) tract, and the product clones were
screened by dideoxynucleotide sequencing (M. Biggen et al. 15
(1983) Proc. Nat. Acad. Sci. USA 80:3963). The mutagenic
oligonucleotide
used
was
~(GACATAGATCTAATAATAAC). A single A residue from the oligo(A) was retained to preserve the BglII site at the 5'
boundary of the core promoter. pB3IC4 is the plasmid which 20
lacks the oligo(A) tract in the subgenomic promoter region.
pB3SG5, 5R, 9, 10, 11, 13, 14, 15, 21, 22: Copies of the
AvaI- Sac1 fragment of pB3TW were inserted as duplications in the indicated sites of the RNA3 cDNA region of
pB3TP7: pB3SG5: XbaI; pB3SG7: ClaI; pB3SG9: ClaI, 25
XbaI; pB3SG10: XbaI,StuI; pB3SG13; ClaI, XbaI, StuI;
pB3SG14: NsiI, XbaI, StuI. Restriction analysis was used to
select those insertions with the same orientation as the
surrounding
rounds of 'Ioning were
required to construct those derivatives with multiple inser- 30
tions of the subgenomic Promoter fragment. In the cases of
multiple promoter constructions, the use of the AvaI-Sac1
fragment rather than the smaller AvaI-SalI fragment allowed
the distinction of the resulting subgenomic RNA species
differentiable in size by gel electrophoresis.
35
pB3SG5R contains theAvaI-SaC1 fragment in the reverse
orientation at the XbaI site of pB3TP7.
pB3SG11 contains the AvaI-SalI fragment as a duplication at the XbaI site
P
~
~
~
~
P
~and P~~~~ contain the
~ Bgln-Sall,
~ BsX1-Sally
~
and~ 40
DdeI-SalI fragments, respectively.
P B ~ S G6R:
~, PB~BB
is ~a pB3TP7 derivative in which a
deletion from base 1168 to the d ~ ~ n s t r e aSac1
m site has
been introduced (R. A. French and P. Ahlquist), (1987) J.
Viral. 61:1457). The AvaI-SacI fragment of P B ~ T Pwas
~ 45
introduced into the X b d site of P B ~ B Bin~ the same
orientation as the surrounding cDNA to create P B ~ S Gand
~,
in the reverse orientation to create pB3SG6R.
pB3IC2,3,5,6: In separate constructions, a BarnHI linker
(CGCGGATCCGCG, New England Biolabs) was inserted 50
in the AvaI and BglII sites of pB3M1 after filling out the
recessed ends with the Klenow DNA polymerase. The small
PstI-BamHI fragment of each of these plasmids was ligated
with the large PstI-BamHI fragment of pB3BC1 (French and
Ahlquist, 1987) to yield intermediate plasmids with the 55
,.DNA duplications of p ~ 3 and
~ ~p 2~ 3 respectively.
~ ~ 3
The small pstI-ClaI fragment of each plasmid was then
exchanged for the small PstI-ClaI fragment of pB3TP8 (to
substitute a bacteriophage T7 promoter for the E- coli
promoter for in vitro transcription) to yield pB3IC2 and 60
pB3IC3. In two additional constructions the large EcoRIHincII fragment of pB3HS1 (French and Ahlquist, 1987)
was ligated with the small AvaI-EcoRI fragment of pB3TP8
or pB3IC4. The large BglII-EcoRI fragments of the resultant
plasmids were ligated individually with the small BamHI- 65
EcoRI fragment of pB3BC1 to yield pB3IC5 and pB3IC6,
respectively.
~~~~~~~9

EXAMPLE 2
In Vitro Transcription, Protoplast Inoculations and
RNA Analysis
, This exmple describes the techniques used to examine
the functionality of BMV wild-type or altered subgenomic
promoter sequences.
Barley protoplasts were isolated as described (L.LoeschFries and T. Hall (1980) J. Gen. Virol. 47:323). In vitro
transcription in the presence of m7GpppG or GpppG, protoplast inoculation and incubation, viral RNA extraction and
analysis and densitometry of the resulting autoradiographs
were ~
~ out as
e d€XTibed
d
Prench
and Ahlquistl lgg7).
was tested in at least three
Each plasmid
Probes for the (+) strand RNA
were a 32P-labelled SP6 transcript from subclone pB3HE1,
which contains the 200 base Hindm-Ec0R.I fragment of 3'
terminal RNA3 cDNA sequences from pB3TP8, or in certain experiments (FIG. 6 of MS) a similar in vitro transcript
complementary to the BglII-Sac11 region of RNA3. Denaturing gel electro~horesisfor negative strand RNA analysis
was carried out on f o d d e h y d e genes (Maniatis et al.,
1982). Probes for the negative strand RNAs were in vitro
transcripts from subclones covering the AvaI-Sac1 region of
BMV RNA3.
primer extension experiments were
out after
inoculation of 106 protop~astswith transcripts o f ~ and~
RNA2 cDNA clones (pB1TP3 and pB2TP5) and transcripts
of the appropriate RNA3 cDNA clone. After incubation for
24 h under continuous light, total nucleic acids were isolated
and dissolved in 15 pl ddH20. 1.5 pl of this nucleic acid was
mixed with 1 ng of 5'-32P labelled d(GCGAGTCATCTTACC) (complementary to bases 2 8 4 2 of BMV RNA4) in
a total volume of 4 pl with 1.5 units of reverse transcriptase
(Life Sciences, Inc.) deoxynucleotides at 25 @I each, and
final concentrations of 25 mM Tris-C1 pH 8.3,5 mM MgCl,,
25 mM KCI, and mM DTT. After incubation for 30
at 37. C., the products were denatured at 95 C. for 3 min. in
an equal
,
volume of 90% fomamide, 20 mM EDTA, 0.1%
xylene cyanol, 0.1% bromphenol blue, and 3 pl aliquots
were electrophoresed on a 12% polyacrylamide, 8.3M urea
gel. Marker lanes were prepared similarly except that each
reaction contained 50 @I of a single deoxynucleotide, and
the template was ssDNA prepared from phage particles
isolated after superinfection of pB3SG6-transformed E. coli
with helper phage M13K07. Sequence comparisons were
made with the assistance of software from the University of
Wisconsin Genetics Computer Group.

EXAMPLE 3
Construction of pB3-SGP and Gene Expression

a cDNA
This example describes the
RNA3 derivative which directs the expression of chloramphenicol acetyl transferase (CAT) activity under the transcription control of the BMV subgenomic promoter, wherein
the expression of the subgenomic promoter-CAT gene COmsite On the RNA3
~ l e xis from a
The subgenomic promoter-CAT gene complex is cloned
as a AvaI-PstI fragment of pB3CA42 (R. French et al. (1986)
Science 23 1:1294). After filling out the single-stranded ends
with Klenow DNA polymerase, this fragment is cloned into
the XbaI site of pB3TP7 after similar treatment to create
flush ends; the resultant plasmid in which the orientation of
the subgenomic promoter-CAT gene complex is the same as

l

5,466,788
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in the surrounding cDNA is called pB3-SGP.
RNA transcripts are introduced into barley protoplasts as
described in Example 2. CAT gene activity is measured as
described in French et al., 1986.

said (+) strand RNA virus further comprises an activating
domain corresponding to the nucleotide sequence from a
B s t X site to a BglII site of the cDNA corresponding to the
RNA of FIG. 2, and wherein said activating domain is
positioned 5' to said subgenomic core promoter sequence.
2. The recombinant DNA molecule of claim 1 wherein
said subgenomic core promoter is the subgenomic promoter
of brome mosaic virus.
3. A recombinant DNA molecule comprising the subgenomic promoter of claim 2 and further comprising a plantexpressible gene under the regulatory control of said subgenomic promoter.
4. The recombinant DNA molecule of claim 2 wherein
said subgenomic promoter
the 'Ore promoter
Sequence from a Bgl' site to a
site Of the
corresponding to the RNA Of
and further comprises
the activating sequence
a Bsm site to a Bgln site
the cDNA corresponding to the RNA of FIG. 2, wherein said
activating domain is located no more than 95 nucleotides
'pStream of a subgenomic
start site.
'. The
DNA
Of
wherein
said subgenomic promoter comprises the core promoter
sequence from a BglII site to a SalI site of the cDNA
corresponding to the RNA of FIG. 2, and farther comprises
the activating sequence from an AvaI site to a BglII site of
the cDNA corresponding to the RNA of FIG. 2, wherein said
activating domain is located no more than 95 nucleotides
upstream of a subgenomic transcription start site.
6. The recombinant DNA molecule of claim 2 further
comprising a second copy of said subgenomic core promoter
and a second copy of said activating domain, wherein said
second copy of said activating domain is positioned to
said second copy of a subgenomic core promoter to form a
second subgenomic promoter and wherein said second subgenomic promoter is positioned within said artificially con-
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EXAMPLE 4
Construction of pBMVSGP and Two-Stage Gene
Expression Controlled by the BMV Subgenomic
Promoter
This example describes the construction of a recombinant
DNA molecule containing the subgenomic promoter of
BMV and the bacterial chloramphenicol acetyltransferase
(CAT) gene, such that expression of the CAT gene is under
the regulatory control of the subgenomic promoter. This
molecule can be used to reduce the BMV subgenomic
promoter-dependent CAT gene into
tissue by any
means known to the art. Treatment of the genetically modito
fied plant tissue by treating with BMV genomic
supply RNA- dependent RNApolymerase activity then turns
on the expression of the CAT gene under the control of the
subgenomic promoter.
The
fragment
P~~~~~~ (R.French et al.
(1986) Science 231:1294) provides the subgenomic Promoter-CAT gene combination. After repairing all singlestranded
with K1enow DNA polymerase, this
fragment is inserted at the BarnHI site of pGA355+26 (G.
An et al. (1986) Mol. Gen. Genet. 203:245). Restriction
'gests are performed to choose the product in
which that the PstI-end is adjacent to the nos promoter, a
poln promoter; this recombinant is PBMVSGP. Thus, a
primary
directed the nos promoter
be a (-1
strand with
to the subgenomic promoter and the CAT
coding region. There is no translation initiation site in the
nos-derived portion of the primary transcript.
pBMVSGP is introduced into tobacco protoplasts using
the technique of electroporation (M. Fromm et al. (1985)
Proc. Natl. Acad. Sci. 82:5824). Primary (-) strand transcripts will be constitutively synthesized by Cellular RNA
polymerase II.
Subgenomic promoter-dependent expression of CAT is
accomplished by introducing BMV RNAs as the source of
RNA-dependent RNA polymerase activity into the genetically modified tobacco protoplasts, as described by L. Loesch-Fries et al. (1985) Virology 143:626. CAT enzymatic
activity is measured as described (French et al. (1986)).
We claim:
1.An artificially constructed recombinant DNA molecule
comprising the nucleotide sequence of a (+) strand plant
RNA virus subgenomic core promoter selected from the
group consisting of tobamoviruses, tobraviruses, bromoviruses, cucumoviruses and alfalfa mosaic virus, wherein said
(+) strand RNA virus comprises a consensus sequence
selected from the group consisting of AUCUAUGUU and
sequences having a single mismatch thereto, and wherein
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structed recombinant DNA molecule to allow functioning of
said second subgenomic promoter within an RNA copy of
said
DNA molecule.
7. An artificially constructed recombinant DNA molecule
40 comprising a subgenomic promoter, wherein said subgenomic promoter comprises a nucleotide sequence from
brome mosaic virus from a BstXI site to a SalI site of the
cDNA corresponding to the RNA of FIG. 2, and duplicate
copies of an activating domain of brome mosaic virus,
45 wherein said duplicate sequence is from an AvaI site to a
BgllI site of the cDNA corresponding to the RNA of FIG. 2,
wherein said duplicate activating domain sequence is
located about 220 nucleotides upstream of a subgenomic
transcription start site, said subgenomic promoter further
50 comprising a consensus sequence selected from the group
consisting of AUCUAUGUU and sequences having a single
mismatch thereto, and said recombinant DNA molecule
further comprising a plant-expressible gene under the regulatory control of said subgenomic promoter.
55
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